Regeneron Statistics and Revenue Totals for 2024
Last Updated on: January 14th, 2024
Here are a few of the most interesting Regeneron statistics and facts I was able to dig up including restaurant count, revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Critical sections of this article:
Regeneron Facts
Here is pretty much everything you ever wanted to know about Regeneron.
- Website: Official Website
- Year Founded: 1988
- Headquarters: Eastview, NY
- Founder(s): Leonard Schleifer, Eric Manvers Shooter
- Current Chief Executive: Leonard Schleifer
Regeneron Pharmaceuticals, Inc. is a renowned American biotechnology company specializing in the development of innovative drugs and therapies for various medical conditions. Founded in 1988, Regeneron has gained prominence for its pioneering work in the fields of biomedicine and biotechnology, particularly in the development of monoclonal antibody therapies.
One of Regeneron’s most notable achievements is the development of monoclonal antibody therapies, such as REGN-COV2 (casirivimab and imdevimab), which gained emergency use authorization for the treatment of COVID-19. This innovative approach involves creating antibodies that mimic the body’s natural immune response to combat diseases.Regeneron has a diverse pipeline of drug candidates and is actively involved in research and development across various therapeutic areas, including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Their drug EYLEA (aflibercept) is widely used for treating retinal diseases like wet age-related macular degeneration and diabetic macular edema.
Regeneron Statistics
Regeneron Revenue Totals
Regeneron annual revenue:
- 2022: $12.172 billion
- 2021: $16.071 billion
- 2020: $8.497 billion
- 2019: $7.863 billion
- 2018: $6.710 billion
- 2017: $5.872 billion
- 2016: $4.860 billion
- 2015: $4.104 billion
- 2014: $2.820 billion
Regeneron annual net income:
- 2021: $9.075 billion
- 2020: $3.513 billion
- 2019: $2.115 billion
- 2018: $2.444 billion
- 2017: $1.198 billion
- 2016: $895 million
- 2015: $636 million
Please note that some of these numbers are easier to find than others. A few of these Regeneron statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags:
